mulpleo (previously lusutrombopag shionogi)
shionogi b.v. - lusutrombopag - trombocytopenie - antihemorragica - mulpleo is geïndiceerd voor de behandeling van ernstige trombocytopenie bij volwassen patiënten met een chronische leverziekte ondergaan invasieve procedures.
dicynone 250 mg tabl.
omedicamed unipessoal lda - etamsylaat 250 mg - tablet - 250 mg - etamsylaat 250 mg - etamsylate
dicynone 250 mg/2 ml inj. opl. i.m./i.v. amp.
omedicamed unipessoal lda - etamsylaat 250 mg/2 ml - oplossing voor injectie - 250 mg/2 ml - etamsylaat 125 mg/ml - etamsylate
hemosilate 125 mg/ml oplossing voor injectie
ecuphar veterinaria s.l.u. - etamsylatum (ln) - oplossing voor injectie - etamsylatum (ln) 125 mg/ml, - etamsylate - geiten; honden; katten; paarden; runderen; schapen; varkens
hemosilate 125 mg/ml inj. opl. i.v./i.m. flac.
ecuphar veterinaria (decommissioned) s.l.u. - etamsylaat 125 mg/ml - oplossing voor injectie - 125 mg/ml - etamsylaat 125 mg/ml - etamsylate - hond; kat; paard; varken; schaap; rund; geit
doptelet
swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocytopenie - antihemorragica - doptelet is geïndiceerd voor de behandeling van ernstige trombocytopenie bij volwassen patiënten met een chronische leveraandoening die zijn gepland om te worden onderworpen aan een invasieve procedure. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. corticosteroïden, immunoglobulinen).
tavlesse
instituto grifols s.a. - fostamatinib disodium - trombocytopenie - andere systemische hemostatics - tavlesse is geïndiceerd voor de behandeling van chronische immuun trombocytopenie (itp) bij volwassen patiënten die refractair zijn voor andere behandelingen.
nplate
amgen europe b.v. - romiplostim - purpura, thrombocytopenic, idiopathic - antihemorragica - adults:nplate is indicated for the treatment of primary immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. corticosteroïden, immunoglobulinen). paediatrics:nplate is indicated for the treatment of chronic primary immune thrombocytopenia (itp) in paediatric patients one year of age and older who are refractory to other treatments (e. corticosteroïden, immunoglobulinen).
revolade
novartis europharm limited - eltrombopag - purpura, thrombocytopenic, idiopathic - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 en 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 en 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
hemlibra
roche registration limited - emicizumab - hemophilia a - antihemorragica - hemlibra is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia a (congenital factor viii deficiency):with factor viii inhibitorswithout factor viii inhibitors who have:severe disease (fviii < 1%)moderate disease (fviii ≥ 1% and ≤ 5%) with severe bleeding phenotype. hemlibra kan worden gebruikt in alle leeftijd groepen.